ALDX News

Pomerantz LLP Informs Shareholders of Securities Class Action Against Aldeyra Therapeutics, Inc. – ALDX

ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving Aldeyra Therapeutics, Inc. – ALDX

Pomerantz LLP Informs Shareholders of Class Action Filing Against Aldeyra Therapeutics, Inc. – ALDX

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

HELE INVESTIGATION ALERT: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Helen of Troy (HELE) Ready to Announce with Confidence?

ALDX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 Ready to Announce with Confidence?

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against Aldeyra Therapeutics, Inc. – ALDX